VKH
GYRE icon

Virtu KCG Holdings’s Gyre Therapeutics GYRE Stock Holding History

Virtu KCG Holdings’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$103K Buy
+2,957
New +$106K ﹤0.01% 2408
2017
Q1 		– Sell
-340
Closed -$25K – 3375
2016
Q4 		$25K Buy
+340
New +$30.6K ﹤0.01% 3208
2015
Q1 		– Sell
-52
Closed -$107K – 3420
2014
Q4 		$107K Buy
+52
New +$100K ﹤0.01% 3196
2014
Q1 		– Sell
-25
Closed -$81K – 3724
2013
Q4 		$81K Buy
+25
New +$98.6K ﹤0.01% 3498

Other funds holding GYRE

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu KCG Holdings's GYRE Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Gyre Therapeutics (GYRE) in Q2 2017: 2,957 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #2408 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in GYRE as recently as Q4 2016.

Virtu KCG Holdings first reported a position in GYRE in Q4 2013 and has held it in 4 quarters since. The position peaked at $107K in Q4 2014. 23 funds tracked by Wall St. Rank hold GYRE as of Q2 2017.

  • Virtu KCG Holdings held 2,957 shares of Gyre Therapeutics worth $103K as of Q2 2017.
  • Gyre Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • Gyre Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2408 holding.
  • Virtu KCG Holdings first reported a position in Gyre Therapeutics in Q4 2013 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Gyre Therapeutics position peaked at $107K in Q4 2014.
  • 23 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.